VANCOUVER, BRITISH COLUMBIA--(Marketwire - Aug. 22, 2012) - Pyng Medical Corp. (TSX VENTURE:PYT) (the "Company") announced that it has granted a total of 530,000 options to purchase common shares of the Company to certain directors, officers and employees of the Company in accordance with the Company's stock option plan. The options will expire four years from the date of grant and have an exercise price of $0.07 per common share. One-third of the options granted will vest every six months for a period of 18 months.
The Company has determined that the exemptions from the various requirements of the TSX Venture Exchange Policies are available for the granting of these options.
More information about the Company is available on SEDAR at www.sedar.com under the Company's profile and on our website: www.pyng.com.
About Pyng Medical Corp.
Pyng Medical Corp. commercializes award-winning trauma and resuscitation products for front-line critical care personnel. Pyng's expanded product portfolio includes a variety of innovative, lifesaving tools. With growing markets in North America, Europe and Asia, Pyng offers user-preferred medical devices for use by hospital staff, emergency medical services and military forces worldwide.
Neither the TSX Venture Exchange nor its Regulatory Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.